PolyPeptide Group AG
SIX:PPGN.SW
31.95 (CHF) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 320.372 | 280.978 | 282.126 | 224.296 | 202.613 | 179.574 |
| Cost of Revenue
| 315.73 | 228.987 | 182.426 | 151.108 | 131.039 | 117.45 |
| Gross Profit
| 4.642 | 51.991 | 99.7 | 73.188 | 71.574 | 62.124 |
| Gross Profit Ratio
| 0.014 | 0.185 | 0.353 | 0.326 | 0.353 | 0.346 |
| Reseach & Development Expenses
| 1.465 | 1.243 | 1.407 | 1.312 | 14.375 | 12.307 |
| General & Administrative Expenses
| 17.181 | 34.543 | 27.577 | 23.758 | 9.069 | 8.675 |
| Selling & Marketing Expenses
| 1.579 | 4.905 | 3.864 | 3.64 | 1.237 | 1.314 |
| SG&A
| 18.76 | 40.627 | 32.498 | 28.013 | 10.306 | 9.989 |
| Other Expenses
| 0 | 0 | 0 | 0 | 13.344 | 12.068 |
| Operating Expenses
| 41.11 | 42.342 | 37.037 | 32.294 | 38.025 | 34.364 |
| Operating Income
| -36.468 | 12.527 | 67.401 | 44.311 | 33.549 | 27.76 |
| Operating Income Ratio
| -0.114 | 0.045 | 0.239 | 0.198 | 0.166 | 0.155 |
| Total Other Income Expenses Net
| -21.775 | -4.96 | -7.553 | -6.626 | -3.316 | 1.694 |
| Income Before Tax
| -58.243 | 7.567 | 59.848 | 37.685 | 30.233 | 29.454 |
| Income Before Tax Ratio
| -0.182 | 0.027 | 0.212 | 0.168 | 0.149 | 0.164 |
| Income Tax Expense
| -6.803 | 0.2 | 12.59 | 6.35 | 4.496 | 5.634 |
| Net Income
| -51.44 | 7.767 | 47.258 | 31.335 | 25.737 | 23.82 |
| Net Income Ratio
| -0.161 | 0.028 | 0.168 | 0.14 | 0.127 | 0.133 |
| EPS
| -1.56 | 0.24 | 1.47 | 1.04 | 0.86 | 0.79 |
| EPS Diluted
| -1.56 | 0.24 | 1.47 | 1.04 | 0.86 | 0.79 |
| EBITDA
| -22.151 | 33.053 | 83.456 | 58.437 | 49.403 | 42.586 |
| EBITDA Ratio
| -0.069 | 0.118 | 0.296 | 0.261 | 0.244 | 0.237 |